Marks first EMA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and…
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Sept. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused…
MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing…
BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid…
BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the…
MORRISTOWN, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment…
- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024…
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone's footprint, hire hundreds of additional scientists, and seize…
Former Takeda Ventures Director Joins Investment Company to Spur Systems Biology Business Creation and Innovation TOKYO, Sept. 4, 2024 /PRNewswire/…
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…